Evidence map›Paper›PMID 19064257›Full record

ArticleCell host & microbe2008

The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites.

Min Yu, T R Santha Kumar, Louis J Nkrumah, Alida Coppi, Silke Retzlaff, Celeste D Li, Brendan J Kelly, Pedro A Moura, Viswanathan Lakshmanan, Joel S Freundlich and 19 more

Abstract read
In one paragraph

Article in Cell host & microbe, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A pyruvate transporter in the apicoplast of apicomplexan parasites.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. M-iScience · 2024
    Article
  14. Article
  15. Article
  16. Apicoplast-Resident Processes: Exploiting the Chink in the Armour ofAdvances in pharmacological and pharmaceutical sciences · 2024
    Review
  17. Article
  18. Article
  19. The mitochondrion ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Min YuDepartment of Microbiology, Columbia University, New York, NY 10032, USA.
T R Santha Kumar
Louis J Nkrumah
Alida Coppi
Silke Retzlaff
Celeste D Li
Brendan J Kelly
Pedro A Moura
Viswanathan Lakshmanan
Joel S Freundlich
Juan-Carlos Valderramos
Catherine Vilcheze
Mark Siedner
Jennifer H-C Tsai
Brie Falkard
Amar Bir Singh Sidhu
Lisa A Purcell
Paul Gratraud
Laurent Kremer
Andrew P Waters
Guy Schiehser
David P Jacobus
Chris J Janse
Arba Ager
William R Jacobs
James C Sacchettini
Volker Heussler
Photini Sinnis
David A Fidock

Funding

Novel Drug Discovery against P. falciparum ENRP01AI060342 · NIAID · TEXAS A&M AGRILIFE RESEARCH · PI SACCHETTINI, JAMES C · 2004 to 2008
$3.9M
Structure and Function of the Circumsporozoite ProteinR01AI056840 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SINNIS, PHOTINI · 2005 to 2014
$3.8M
NIAID NIH HHS P01 AI060342NIAID NIH HHS R01 AI056840Wellcome Trust 083811
6 · The paper itself

Abstract

The fatty acid synthesis type II pathway has received considerable interest as a candidate therapeutic target in Plasmodium falciparum asexual blood-stage infections. This apicoplast-resident pathway, distinct from the mammalian type I process, includes FabI. Here, we report synthetic chemistry and transfection studies concluding that Plasmodium FabI is not the target of the antimalarial activity of triclosan, an inhibitor of bacterial FabI. Disruption of fabI in P. falciparum or the rodent parasite P. berghei does not impede blood-stage growth. In contrast, mosquito-derived, FabI-deficient P. berghei sporozoites are markedly less infective for mice and typically fail to complete liver-stage development in vitro. This defect is characterized by an inability to form intrahepatic merosomes that normally initiate blood-stage infections. These data illuminate key differences between liver- and blood-stage parasites in their requirements for host versus de novo synthesized fatty acids, and create new prospects for stage-specific antimalarial interventions.

Indexed as

AnimalsAntimalarialsGene DeletionLiverMalariaMiceMice, Inbred C57BLMutagenesis, InsertionalParasitemiaPlasmodium bergheiPlasmodium falciparumProtozoan ProteinsTriclosanAntimalarialsProtozoan ProteinsTriclosan

Identifiers

PMID19064257
PMCPMC2646117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.